Monday, September 14, 2026

Is the EV Market Shrinking? Key Insights on GM, Ford, and Samsung SDI’s JV Restructuring

South Korean battery firms and U.S. automakers are restructuring joint ventures to expand their presence in the electric vehicle market.

Navigating FDA Challenges: How SK Biopharmaceuticals Plans to Move Forward with Opacalim

SK Biopharm will maintain its development and commercialization plans for epilepsy drug candidate Opacalim despite FDA's partial clinical hold.

Samsung SDI Bets on LFP Batteries, Eyes Mass Production by 2028 in U.S. and Europe

Samsung SDI aims for profitability in Q4, focusing on LFP batteries for EVs and anticipating growth in small battery sales.

Tag: Hadlima

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

K-Bio Targets the U.S. Market: Celltrion and Samsung Bioepis Close in on Originator Drugs

Celltrion and Samsung Bioepis are expanding in the U.S. market, showing strong growth in biosimilars like Zymfentra and Hadlima.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.